Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Myeloid 1

Conditions

Multiple Myeloma 265Leukemia, Lymphocytic, Chronic, B-Cell 66Lymphoma, Large B-Cell, Diffuse 60Neoplasms, Plasma Cell 50Lymphoma, Follicular 45Lymphoma, Mantle-Cell 42Lymphoma 41Recurrence 38Lymphoma, B-Cell, Marginal Zone 31Leukemia 30Leukemia, Myeloid, Acute 27Lymphoma, B-Cell 19Lymphoma, Non-Hodgkin 17Myelodysplastic Syndromes 16Waldenstrom Macroglobulinemia 15Smoldering Multiple Myeloma 13Hodgkin Disease 13Lymphoma, T-Cell, Peripheral 12Neoplasms 11Lymphoma, T-Cell 9Prostatic Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, T-Cell, Cutaneous 8Immunoglobulin Light-chain Amyloidosis 8Burkitt Lymphoma 8Sezary Syndrome 7Neoplasm, Residual 7Mycosis Fungoides 7Lymphoma, Large-Cell, Anaplastic 7Leukemia, Plasma Cell 6

Interventions

fludarabine 3Tacrolimus 3Melphalan 3Cyclophosphamide 3Busulfan 3thymoglobulin 2fludarabine phosphate 2Whole-Body Irradiation 2Rituximab 2Mycophenolic Acid 2Clofarabine 2Antilymphocyte Serum 2trametinib 1etoposide phosphate 1dabrafenib 1cobimetinib 1Thiotepa 1Specimen Handling 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Filgrastim 1Etoposide 1Enzyme-Linked Immunosorbent Assay 1Deferasirox 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Histiocytosis, Langerhans-Cell × Lenalidomide × Clear all
NCT02523040 2025-12-10

Lenalidomide for Adult Histiocyte Disorders

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
12 enrolled 14 charts
MyeloidSarcoma

Histiocytosis, Langerhans-Cell, Erdheim-Chester Disease, Histiocytic Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡